CONMED CORP (CNMD) Stock Fundamental Analysis
USA - NYSE:CNMD - US2074101013 - Common Stock
51.17 USD
+0.69 (+1.37%)
We assign a fundamental rating of 6 out of 10 to CNMD. CNMD was compared to 191 industry peers in the Health Care Equipment & Supplies industry. CNMD has an excellent profitability rating, but there are some minor concerns on its financial health. CNMD is valued quite cheap, while showing a decent growth score. This is a good combination! This makes CNMD very considerable for value investing!
1. Profitability
1.1 Basic Checks
CNMD had positive earnings in the past year.
In the past year CNMD had a positive cash flow from operations.
CNMD had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CNMD had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 4.73%, CNMD belongs to the best of the industry, outperforming 81.68% of the companies in the same industry.
With an excellent Return On Equity value of 10.99%, CNMD belongs to the best of the industry, outperforming 86.39% of the companies in the same industry.
With an excellent Return On Invested Capital value of 7.55%, CNMD belongs to the best of the industry, outperforming 83.77% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 8.46%.
The 3 year average ROIC (5.34%) for CNMD is below the current ROIC(7.55%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROIC | 7.55% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
CNMD's Profit Margin of 8.31% is amongst the best of the industry. CNMD outperforms 80.63% of its industry peers.
In the last couple of years the Profit Margin of CNMD has grown nicely.
With an excellent Operating Margin value of 14.38%, CNMD belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
CNMD's Operating Margin has improved in the last couple of years.
CNMD has a Gross Margin of 56.05%. This is comparable to the rest of the industry: CNMD outperforms 51.83% of its industry peers.
In the last couple of years the Gross Margin of CNMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNMD is still creating some value.
Compared to 1 year ago, CNMD has more shares outstanding
CNMD has more shares outstanding than it did 5 years ago.
CNMD has a better debt/assets ratio than last year.
2.2 Solvency
CNMD has an Altman-Z score of 2.08. This is not the best score and indicates that CNMD is in the grey zone with still only limited risk for bankruptcy at the moment.
CNMD's Altman-Z score of 2.08 is fine compared to the rest of the industry. CNMD outperforms 62.83% of its industry peers.
The Debt to FCF ratio of CNMD is 5.95, which is a neutral value as it means it would take CNMD, 5.95 years of fcf income to pay off all of its debts.
CNMD has a Debt to FCF ratio of 5.95. This is in the better half of the industry: CNMD outperforms 79.06% of its industry peers.
CNMD has a Debt/Equity ratio of 0.88. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.88, CNMD is not doing good in the industry: 75.92% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Altman-Z | 2.08 |
ROIC/WACC1.17
WACC6.47%
2.3 Liquidity
A Current Ratio of 2.23 indicates that CNMD has no problem at all paying its short term obligations.
CNMD's Current ratio of 2.23 is in line compared to the rest of the industry. CNMD outperforms 42.41% of its industry peers.
A Quick Ratio of 1.00 indicates that CNMD should not have too much problems paying its short term obligations.
CNMD has a worse Quick ratio (1.00) than 75.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.38%, which is quite impressive.
The Earnings Per Share has been growing by 9.44% on average over the past years. This is quite good.
CNMD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.94%.
The Revenue has been growing slightly by 6.47% on average over the past years.
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
3.2 Future
Based on estimates for the next years, CNMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.42% on average per year.
CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.42% yearly.
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CNMD is valuated reasonably with a Price/Earnings ratio of 11.40.
CNMD's Price/Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 92.15% of the companies in the same industry.
CNMD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
The Price/Forward Earnings ratio is 10.52, which indicates a very decent valuation of CNMD.
CNMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 92.15% of the companies in the same industry.
CNMD is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 10.52 |
4.2 Price Multiples
92.15% of the companies in the same industry are more expensive than CNMD, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CNMD is valued cheaper than 96.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.68 | ||
| EV/EBITDA | 9.14 |
4.3 Compensation for Growth
CNMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CNMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.19
PEG (5Y)1.21
EPS Next 2Y8.14%
EPS Next 3Y9.42%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.48%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.69, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.29% of the companies listed in the same industry.
CNMD's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.48% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
22.42% of the earnings are spent on dividend by CNMD. This is a low number and sustainable payout ratio.
DP22.42%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
NYSE:CNMD (9/18/2025, 2:22:25 PM)
51.17
+0.69 (+1.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners116.94%
Inst Owner Change-1.49%
Ins Owners0.28%
Ins Owner Change-0.14%
Market Cap1.58B
Analysts73.33
Price Target62.99 (23.1%)
Short Float %6.79%
Short Ratio4.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.48% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP22.42%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)0.37%
Max EPS beat(2)14.78%
EPS beat(4)4
Avg EPS beat(4)7%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.79%
EPS beat(12)10
Avg EPS beat(12)-0.43%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)1
Avg Revenue beat(2)-0.12%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)-8.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2%
EPS NY rev (1m)1.69%
EPS NY rev (3m)1.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.4 | ||
| Fwd PE | 10.52 | ||
| P/S | 1.19 | ||
| P/FCF | 10.68 | ||
| P/OCF | 9.59 | ||
| P/B | 1.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.14 |
EPS(TTM)4.49
EY8.77%
EPS(NY)4.87
Fwd EY9.51%
FCF(TTM)4.79
FCFY9.36%
OCF(TTM)5.34
OCFY10.43%
SpS42.85
BVpS32.4
TBVpS-13.11
PEG (NY)1.19
PEG (5Y)1.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROCE | 9.38% | ||
| ROIC | 7.55% | ||
| ROICexc | 7.68% | ||
| ROICexgc | 25.98% | ||
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% | ||
| FCFM | 11.18% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexcg growth 3Y14.62%
ROICexcg growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 23.31% | ||
| Cap/Sales | 1.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.68% | ||
| Profit Quality | 134.53% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.08 |
F-Score7
WACC6.47%
ROIC/WACC1.17
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y11.97%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year45.54%
EBIT Next 3Y17.93%
EBIT Next 5YN/A
FCF growth 1Y832.34%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y345.31%
OCF growth 3Y14.3%
OCF growth 5Y11.92%